Goldfinch Biopharma Company

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.

Founded Date: 2015
Estimated Revenue: $1M to $10M
Employee Number: 11-50
Industry: PharmTech
Technology: Neurological Disorders
Headquarters: Cambridge, Massachusetts, United States
Funding Status: Early Stage Venture